ÌÇÐÄvlog´«Ã½

Europe Esoteric Testing Market Analysis

The Europe Esoteric Testing Market size is estimated at USD 7.80 billion in 2024, and is expected to reach USD 13.23 billion by 2029, growing at a CAGR of 11.23% during the forecast period (2024-2029).

The European esoteric testing market is anticipated to grow with the rising burden of chronic diseases, rare diseases, and increasing research expenditure. The rising prevalence of chronic illnesses and uncommon ailments in Europe is spurring the need for specialized testing. The widespread occurrence of diseases such as cancer, infectious agents, and unusual genetic conditions calls for cutting-edge diagnostic techniques to enable precise and timely recognition, contributing to market growth.

The region has an increasing burden of several chronic and rare diseases that require esoteric testing to be diagnosed on time. For instance, as per the International Diabetes Federation (IDF), in February 2022, over 4.47 million adults were reported to have diabetes in the total adult population in Italy, which was equivalent to a prevalence rate of 9.9%. It was also stated that over 1.2 million children and adolescents aged 19 years or less were reported to have type-1 diabetes. Thus, the growing burden of type I and type II diabetes is expected to increase demand for diagnosis with esoteric testing, which is likely to support the growth of the market.

Similarly, according to the data updated by the Spanish Network of Cancer Registries (REDECAN) in January 2023, approximately 279,260 new cases of cancer were expected to occur in Spain by the end of 2023, out of which 42,721 new cases of colorectal cancer, 31,282 cases of lung cancer, and 21,694 cases of urinary bladder cancer. Thus, with the vast patient base of chronic patients, the demand for esoteric tests is expected to increase for the timely or early diagnosis of underlying diseases, boosting the market’s growth during the forecast period.

Furthermore, recent developments by service providers are expected to increase the availability of esoteric testing in the region, which is likely to boost the market’s growth. For instance, in April 2022, Minaris Medical obtained the European Union In Vitro Diagnostic Medical Devices Regulation certification for fecal occult blood test reagents. Similarly, in November 2023, Arup Laboratories achieved the Conformité Européenne (CE) certification for the single-site use of AAV5 DetectCDx, aligning with the European Union's In Vitro Diagnostic Medical Devices Regulation. Developed in collaboration with BioMarin Pharmaceutical Inc., AAV5 DetectCDx functions as a companion diagnostic, aiding in the identification of adult patients eligible for BioMarin's groundbreaking gene therapy for severe hemophilia A, valoctocogene roxaparvovec-rvox (ROCTAVIAN). Thus, the launch and approval of innovative esoteric tests in the market are expected to contribute to the market's growth during the forecast period.

Therefore, owing to the factors above, the market studied is anticipated to grow during the forecast period. However, the stringent regulatory scenario is likely to impede the market’s growth.

Europe Esoteric Testing Market Trends

Oncology Segment is Expected to Exhibit Significant Market Growth During the Forecast Period

Europe Esoteric Testing Industry Segmentation

As per the scope of the report, esoteric testing is used to analyze and detect rare substances and molecules. The European esoteric testing market is segmented by test type, technology, and geography. By test type, the market is segmented into endocrinology, infectious disease, oncology, neurology, toxicology, and other test types. By technology, the market is segmented into flow cytometry, chemiluminescence immunoassay, mass spectrometry, radioimmunoassay, and other technologies. By geography, the market is segmented into Germany, the United Kingdom, France, Italy, Spain, and Rest of Europe. The report offers the value (USD) for all the above segments.